Literature DB >> 274588

Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia.

D S Ettinger, W G Harker, H W Gerry, R C Sanders, R Saral.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 274588     DOI: 10.1001/jama.239.23.2472

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

2.  Acute renal failure induced by hyperphosphatemia in acute lymphoblastic leukemia.

Authors:  B S Kaplan; D Hébert; R E Morrell
Journal:  Can Med Assoc J       Date:  1981-02-15       Impact factor: 8.262

Review 3.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.

Authors:  Eliot C Heher; Samuel O Thier; Helmut Rennke; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 8.237

4.  Hyperphosphatemia in tumor lysis syndrome: the role of hemodialysis and continuous veno-venous hemofiltration.

Authors:  A Sakarcan; R Quigley
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

5.  Hypophosphatemia accompanying blastic crisis in a patient with malignant lymphoma.

Authors:  J Perek; M Mittelman; U Gafter; M Djaldetti
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 6.  Tumor lysis syndrome: pathogenesis and management.

Authors:  D P Jones; H Mahmoud; R W Chesney
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

7.  Acute phase reaction during chemotherapy in small cell lung cancer.

Authors:  R Milroy; D Shapiro; A Shenkin; S W Banham
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

Review 8.  Hyperphosphatemia Management in Patients with Chronic Kidney Disease.

Authors:  Ahmed M Shaman; Stefan R Kowalski
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.